SPY335.84-2.98 -0.88%
DIA279.57-1.46 -0.52%
IXIC10,910.28-140.19 -1.27%

Argus Research Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $320

Argus Research maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $270 to $320.

Benzinga · 05/15/2020 14:44

Argus Research maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $270 to $320.